HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Monro, J. L. Articles by Keeton, B. R. Search for Related Content PubMed PubMed Citation Articles by Monro, J. L. Articles by Keeton, B. R.

European Journal of Cardio-Thoracic Surgery, Vol 7, 360-363, Copyright © 1993 by European Association for Cardio-thoracic Surgery

ARTICLES

The outcome of antibiotic sterilised aortic homografts used in the Fontan procedure

JL Monro, AP Salmon and BR Keeton
Department of Cardiac Surgery, General Hospital Southampton, Hampshire, UK.

Between 1977 and 1988, 27 patients between the ages of 4 and 22 years (mean 8.9) underwent a Fontan procedure with the use of an antibiotic sterilised aortic homograft. There were 15 patients with tricuspid atresia, 9 with univentricular heart and 3 others. The homograft was anastomosed to a right-sided pulmonary artery in ten, to a left-sided main pulmonary artery in eight and in nine patients the homograft connected the right atrium to the right ventricle. There were five early deaths (18.5%) unrelated to the homograft and two late deaths at 7 and 10 years postoperatively. Five patients have required removal of the calcified obstructed homograft with no death. In three patients patches were inserted, but in two patients with good right ventricles a second homograft was inserted. In three of the re-operated patients the homograft lay directly behind the sternum and the femoral artery was exposed and in two of them the femoral artery was cannulated before the chest was opened to control haemorrhage. Of the patients 74% are alive up to 15 years later, 15 with their original homograft. Eight (57%) of those still have their original homograft more than 10 years post- operatively.

This article has been cited by other articles:

				C. Alexiou, D. J. Delany, B. R. Keeton, and J. L. Monro Double-barreled conduit for right atrioventricular connection in tricuspid atresia: A new technique J. Thorac. Cardiovasc. Surg., October 1, 2000; 120(4): 820 - 822. [Full Text] [PDF]

				A. Dore and J. Somerville Right atrioventricular extracardiac conduit as a Fontan modification: late results Ann. Thorac. Surg., January 1, 2000; 69(1): 181 - 185. [Abstract] [Full Text] [PDF]

				L. Kiraly, M. J.R. Dalrymple-Hay, A. P. Salmon, B. R. Keeton, and J. L. Monro The fate of antibiotic sterilized aortic allografts in Fontan circulation: results of the long-term follow-up Eur. J. Cardiothorac. Surg., December 1, 1999; 16(6): 660 - 662. [Abstract] [Full Text] [PDF]

				J. Chanda, R. Kuribayashi, and T. Abe Prevention of Calcification in Glutaraldehyde-Treated Porcine Aortic and Pulmonary Valves Ann. Thorac. Surg., October 1, 1997; 64(4): 1063 - 1066. [Abstract] [Full Text]

				J. Chanda, R. Kuribayashi, and T. Abe NEW-GENERATION VALVED CONDUIT: AN EXPERIMENTAL STUDY J. Thorac. Cardiovasc. Surg., August 1, 1997; 114(2): 218 - 223. [Abstract] [Full Text]